IRON NASDAQ Week ended 31 Jul 2026

Weekly Investor Report

Disc Medicine Inc. · Healthcare · Biotechnology

Open interactive chart View report data
Latest close 77.00 USD
3.9% latest week
Weekly setup

Constructive, but selective

The weekly trend is active. Price is 11.2% above the Trend Line and sits at 62.2% of its 52-week range. The latest completed week returned 3.9%, after a 1.0% four-week move. The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is neither clearly cheap nor expensive. Options positioning is bullish with 37/100 conviction, while the latest news-sentiment score is 52/100. Near-term considerations: volume confirmation is below normal; earnings are due in 4d.

Setup score 46 out of 100
Latest Close 77.00 USD 31 Jul 2026
1W Return 3.9% latest completed week
4W Return 1.0% short-term follow-through
12W Return 12.8% quarterly tape
Trend Breadth 55.8% 29 of 52 weeks active
Volume Ratio 0.7x vs 13-week average
What is working
  • The trend backdrop is active with a 2-week active streak.
  • Price is above the Trend Line, keeping the weekly tape constructive.
  • Price is above Fair Value, showing premium demand versus the model.
  • Activity pressure is positive on the latest completed week.
What could go wrong
  • Activity pressure is weak, so confirmation is not yet broad enough.
  • The share remains more than 20% below its 52-week high.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through 3.9% Latest completed week; four-week move 1.0%. Indicator stack 38/70 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Quiet Activity-pressure buy-signal status for institutional accumulation timing. Options pressure Bullish 37/100 conviction; expected move 10.9%. News sentiment 52/100 52 relevant articles in the latest sentiment read. Event risk 4d Next report is scheduled for 06 Aug 2026; event risk rises as the date approaches.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is active. Price is 11.2% above the Trend Line and sits at 62.2% of its 52-week range. The latest completed week returned 3.9%, after a 1.0% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 0.7x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
6 Feb 13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul 31 Jul
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.4412-week average 0.17

12-week confirmation

Trend active2/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure11/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.44Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers

No recent accumulation markers. No reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is 1.0% over four weeks, 12.8% over 12 weeks, and 30.6% over one year. The current trend has remained active for 2 consecutive weeks.

Performance by holding period

1W3.9%
4W1.0%
12W12.8%
26W-0.4%
52W30.6%
Active trend streak2 weeks
Active weeks in one year29
Trend breadth55.8%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure1.11Latest activity-pressure read.
Pressure change0.4%Four-week change in activity pressure.
Leadership-2.23Latest relative-leadership reading.
RS change64.5%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is neither clearly cheap nor expensive.

Open full factor analysis
Factor week 26 Jul 2026 Financial statements through 31 Mar 2026 Field coverage 79% Model confidence 76%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength64/100Blend of value, momentum, and quality. Underlying universe rank 37; rank 1 is best.
Value56/100Relative valuation strength. Underlying universe rank 45; rank 1 is best.
Quality55/100Profitability and accounting quality. Underlying universe rank 46; rank 1 is best.
Momentum56/100Medium-term price momentum. Underlying universe rank 45; rank 1 is best.
Growth56/100Revenue and earnings growth. Underlying universe rank 45; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
-
Price divided by trailing earnings.
Price / sales
-
Market value relative to trailing revenue.
EV / EBITDA
-
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
-7.3%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
2.9%
Gross profit retained from each unit of revenue.
Operating margin
1991.8%
Operating profit retained from revenue.
Free-cash-flow margin
1679.4%
Free cash flow generated from revenue.
Return on invested capital
-28.4%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
-
Latest one-year revenue growth.
EPS growth
-
Latest one-year earnings-per-share growth.
Free-cash-flow growth
-
Latest one-year free-cash-flow growth.
Piotroski F-score
3/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
-
Cash dividends relative to market value.
Buyback yield
-7.6%
Net share repurchases relative to market value.
Shareholder yield
-7.6%
Dividend yield plus net buyback yield.
Net debt / EBITDA
0.2x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Options positioningBullish

IRON shows bullish options pressure with a 37/100 conviction score, put-call volume ratio of 0.54, expected move of 10.9%, and Sharemaestro trend signal active.

Conviction37/100
Expected move10.9%
Put/call volume0.54
Pressure39
Speculation5
Volatility64
Trend agreement49
Open options detail
Insider activity-

No recent insider transactions are stored for this company.

News sentiment52/100

Weighted news tone is neutral across 52 relevant articles.

11 positive · 34 neutral · 7 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings4dNext report is scheduled for 06 Aug 2026; event risk rises as the date approaches.
Options expected move10.9%Nearest-chain priced movement where available.
52-week drawdown-22.6%Distance below the 52-week high.
13-week volatility2.8%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher15 of 2611 weeks finished lower.
Best week+9.7%Week of 20 Feb.
Worst week-29.8%Week of 13 Feb.
Latest week+3.9%Week of 31 Jul.

Shape of recent returns

Strong gains7
Modest gains8
Flat weeks0
Modest losses8
Sharp losses3
Recent vol2.8%13-week weekly-return volatility.
Base vol7.3%52-week weekly-return volatility.
Up/down split30/22Count of positive and negative weeks in the 52-week window.
Average skew4.6% / -4.4%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape44/100

Trend, activity pressure, participation, and risk combine to a 44/100 tape read.

 Indicator analysis40/100

Latest 12-week confirmation: trend 2/12, activity pressure 11/12, relative leadership 0/12.

Activity pressure 0.44; No reversal markers Factors57/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Buyback Yield rank 85; Small Cap Core rank 50 Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal Options54/100

IRON shows bullish options pressure with a 37/100 conviction score, put-call volume ratio of 0.54, expected move of 10.9%, and Sharemaestro trend signal active.

Bullish · Call-side pressure · Expected move 10.9% Sentiment52/100

Weighted news tone is neutral across 52 relevant articles.

Disc Medicine Inc (IRON) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution Insiders50/100

No recent insider transaction evidence is stored.

 Earnings4d

Next report is scheduled for 06 Aug 2026; event risk rises as the date approaches.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
31 Jul 202677.00 USD3.9%69.24 USD58.48 USD1.11-2.231.9MOn
24 Jul 202674.12 USD-2.7%69.31 USD58.29 USD1.21-5.291.6MOn
17 Jul 202676.15 USD-0.6%69.51 USD58.13 USD1.43-4.231.9MOff
10 Jul 202676.59 USD0.4%69.64 USD57.93 USD1.38-7.593.4MOff
3 Jul 202676.26 USD2.0%70.15 USD57.74 USD1.10-6.284.5MOff
26 Jun 202674.78 USD5.6%70.72 USD57.54 USD0.77-7.185.3MOff
19 Jun 202670.79 USD4.1%71.34 USD57.35 USD0.49-16.003.1MOff
12 Jun 202667.99 USD1.5%72.06 USD57.23 USD0.34-17.212.0MOff
5 Jun 202667.00 USD-3.7%72.80 USD57.11 USD0.29-16.642.3MOff
29 May 202669.57 USD4.1%73.36 USD56.97 USD0.23-17.341.3MOff
22 May 202666.82 USD-0.1%73.91 USD56.79 USD0.12-18.252.4MOff
15 May 202666.86 USD-2.1%74.54 USD56.57 USD-0.01-17.213.4MOff
8 May 202668.26 USD2.0%75.31 USD56.36 USD-0.13-15.732.2MOff
1 May 202666.91 USD-2.8%75.36 USD56.13 USD-0.30-12.782.0MOff
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.